Zobrazeno 1 - 10
of 138
pro vyhledávání: '"duchenne muscular dystropy"'
Autor:
H. I. Ibrahim, A.H. Hasson
Publikováno v:
Ibn Al-Haitham Journal for Pure and Applied Sciences, Vol 20, Iss 1 (2017)
Six females definite Duchennc carriers and 8 females of possible carriers were examine in this study by serum C.P.K after exercise and muscle Biopsy for histochemical study. This st udy was compared with that of normal person. The scnm1 C.P.K was
Externí odkaz:
https://doaj.org/article/8cd10af981cf467a809fc20d5b358ba8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Progress in Modern Biomedicine. Jul2022, Vol. 22 Issue 14, p2784-2790. 7p.
Autor:
Graeme R. Frank, R E Smith
Publikováno v:
Journal of pediatric endocrinologymetabolism : JPEM. 14(2)
We describe a patient with Duchenne muscular dystropy and growth hormone deficiency in whom treatment with human growth hormone for 2 years resulted in improved growth velocity without any detrimental effect on muscle strength.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a23d72311c8a2dd68898920237e280de
https://pubmed.ncbi.nlm.nih.gov/11305801
https://pubmed.ncbi.nlm.nih.gov/11305801
Publikováno v:
Neuromuscular Disorders. 22:876-877
The North Star Ambulatory Assessment (NSAA) is a clinician-rated measure of ambulation in Duchenne muscular dystrophy (DMD). A key role of the NSAA is to monitor disease progression and treatment impact (e.g. steroids). However, to date, the responsi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe22e2933d7e05c1de43c98382cd6892
https://doi.org/10.1016/j.nmd.2012.06.244
https://doi.org/10.1016/j.nmd.2012.06.244
Publikováno v:
In Neuromuscular Disorders October 2012 22(9-10):876-877
Autor:
Silva, E.C., Machado, D.L., Godoy, A.J., Resende, M.B.D., Silva, R.F., Zanoteli, E., Reed, U.C.
Publikováno v:
In Neuromuscular Disorders October 2011 21(9-10):705-705
Autor:
Mohammad Mahdi Ghahramani Seno, Ian R. Graham, George Dickson, Takis Athanasopoulos, Mark R. Crompton, Marita Pohlschmidt, Ken Laing
Publikováno v:
Molecular Therapy. 11:S101-S102
Duchenne Muscular Dystrophy (DMD) is one of a group of genetically heterogeneous muscular dystrophies that are characterized by progressive weakness and wasting of skeletal muscle. Loss of myofibres occurs in response to a deficiency of dystrophin, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d077bb2479feffaebe197fc158a7c41
https://doi.org/10.1016/j.ymthe.2005.06.261
https://doi.org/10.1016/j.ymthe.2005.06.261
Autor:
L. Sorbera, A.E. Brown
Publikováno v:
Drugs of the Future. 38:395
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b703202e1717e1bb93406fedb24e7b66
https://doi.org/10.1358/dof.2013.038.06.1964713
https://doi.org/10.1358/dof.2013.038.06.1964713